Donnelly Ronald F
, MSc(Chem), BSc(Pharm), is Product Development Pharmacist with the Department of Pharmaceutical Sciences, The Ottawa Hospital (Civic Campus), Ottawa, Ontario.
Can J Hosp Pharm. 2011 May;64(3):192-8. doi: 10.4212/cjhp.v64i3.1022.
Pantoprazole sodium, a proton-pump inhibitor, is approved for the short-term treatment of several types of ulcer, Zollinger-Ellison syndrome, and gastroesophageal reflux disease.
To determine the physical compatibility and chemical stability of ethylenediaminetetra-acetic acid (EDTA)-free pantoprazole in glass vials, polypropylene syringes, and polyvinylchloride (PVC) minibags, after storage at 2°C to 8°C with protection from light or at 20°C to 25°C with exposure to light.
Solutions of pantoprazole 4 mg/mL reconstituted in 0.9% sodium chloride (normal saline [NS]) were stored in glass vials at 20°C to 25°C. Similar solutions were transferred to polypropylene syringes and stored at 2°C to 8°C. Stock solution was further diluted, in 5% dextrose in water (D5W) or NS, to 0.4 or 0.8 mg/mL, and samples were then packaged in PVC minibags for storage at 2°C to 8°C or at 20°C to 25°C. Samples collected on days 0, 2, 3, 7, 14, 21, and 28 were analyzed in duplicate with a stability-indicating high-performance liquid chromatography assay.
Pantoprazole 4 mg/mL was stable (i.e., retained at least 90% of initial concentration) for 3 days when stored in glass vials at 20°C to 25°C or for 28 days when stored in polypropylene syringes at 2°C to 8°C. Pantoprazole 0.4 mg/mL diluted in D5W and stored in PVC minibags was stable for 2 days at 20°C to 25°C or for 14 days at 2°C to 8°C. At 0.8 mg/mL, pantoprazole in D5W was stable for 3 days at 20°C to 25°C or 28 days at 2°C to 8°C. Pantoprazole diluted to either 0.4 or 0.8 mg/mL in NS and stored in PVC minibags was stable for 3 days at 20°C to 25°C or 28 days at 2°C to 8°C.
The present study confirmed or extended previously reported expiry dates for pantoprazole sodium packaged in glass vials, polypropylene syringes, and PVC minibags.
泮托拉唑钠是一种质子泵抑制剂,已被批准用于短期治疗多种类型的溃疡、卓艾综合征和胃食管反流病。
确定不含乙二胺四乙酸(EDTA)的泮托拉唑在玻璃小瓶、聚丙烯注射器和聚氯乙烯(PVC)迷你袋中的物理相容性和化学稳定性,在2℃至8℃避光储存或在20℃至25℃光照条件下储存之后。
将泮托拉唑4mg/mL溶解于0.9%氯化钠(生理盐水[NS])中得到的溶液,在20℃至25℃储存于玻璃小瓶中。类似溶液转移至聚丙烯注射器中并在2℃至8℃储存。储备溶液进一步用5%葡萄糖水溶液(D5W)或生理盐水稀释至0.4或0.8mg/mL,然后将样品包装于PVC迷你袋中,在2℃至8℃或20℃至25℃储存。在第0、2、3、7、14、21和28天采集的样品,用稳定性指示高效液相色谱法进行双份分析。
泮托拉唑4mg/mL在20℃至25℃储存于玻璃小瓶中时3天内稳定(即保留至少90%的初始浓度),或在2℃至8℃储存于聚丙烯注射器中时28天内稳定。泮托拉唑0.4mg/mL稀释于D5W中并储存于PVC迷你袋中,在20℃至25℃稳定2天,或在2℃至8℃稳定14天。浓度为0.8mg/mL时,泮托拉唑在D5W中在20℃至25℃稳定3天,或在2℃至8℃稳定28天。泮托拉唑稀释至0.4或0.8mg/mL于生理盐水中并储存于PVC迷你袋中,在20℃至25℃稳定3天,或在2℃至8℃稳定28天。
本研究证实或延长了先前报道的玻璃小瓶、聚丙烯注射器和PVC迷你袋包装的泮托拉唑钠的有效期。